A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):
|Three Months Ended March 31, 2016||Three Months Ended March 31, 2015|
|loss per share||$||(1,336||)||17,081||$||(0.08||)||$||(1,380||)||15,892||$||(0.09||)|
|Diluted loss per share||$||(1,336||)||17,081||$||(0.08||)||$||(1,380||)||15,892||$||(0.09||)|
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018